shutterstock
Solcara Health Blog

What a Longevity Blood Panel Actually Measures (and What a Standard Charleston Physical Misses)

A standard physical tells you a problem has arrived. A longevity panel is built to show it coming, with the markers your annual misses.

An active older couple laughing while hiking a sunny coastal trail lined with palms.
The right panel is not the longest list of tests. It is the one a clinician reads with you.
A standard annual physical usually checks your blood count, a basic metabolic panel, a standard lipid panel, and often your HbA1c and thyroid. That is a reasonable baseline, but it misses the markers that catch cardiovascular and metabolic risk years earlier: ApoB, Lp(a), high-sensitivity CRP, and fasting insulin. A longevity blood panel adds those, and they change the picture. These markers refine your real risk; they are not a crystal ball, but they tell you things a normal physical simply does not look for.[1][2]

This page is the neutral explainer the lab marketing pages skip: what each of these biomarkers actually measures, why it matters, which ones your standard physical already covers, and which ones it leaves out. The point is not to alarm you or to sell you the longest possible test list. It is to help you understand what you are measuring, so the numbers mean something.

Key takeaways
  • A standard physical typically includes a CBC, a metabolic panel, a standard lipid panel, and often HbA1c and thyroid, but usually does not include ApoB, Lp(a), hs-CRP, or fasting insulin.
  • ApoB counts the actual number of artery-clogging particles, which can reveal risk that a normal LDL cholesterol looks fine. Major guidelines list a high ApoB as a risk-enhancing factor.[1]
  • Lp(a) is a genetic cardiovascular risk factor that affects roughly 1 in 5 people, is not lowered much by diet or statins, and is measured once in a lifetime. A standard lipid panel does not check it.[2]
  • hs-CRP measures silent inflammation. In the JUPITER trial, people with normal cholesterol but elevated hs-CRP who took a statin had a 44 percent lower relative risk of major cardiovascular events.[3]
  • Fasting insulin and HOMA-IR can flag insulin resistance years before blood sugar rises, because the pancreas compensates until it cannot.[4]
  • These markers inform risk; they do not predict your future. A good clinic interprets them together, not as a scary list of numbers.
Section 01 / Standard physical

What a standard physical actually checks

Let us start with what you almost certainly already get. A typical annual physical with bloodwork includes a complete blood count, a metabolic panel that covers your fasting glucose, kidney function, electrolytes, and liver enzymes, a standard lipid panel, and frequently an HbA1c and a thyroid test. That is a solid foundation, and for many people it is enough to catch the obvious problems. Nothing here is wrong, and a longevity panel does not replace it.

The limitation is not in what those tests get wrong, but in what they do not look at. Your standard lipid panel reports a calculated LDL cholesterol, which measures the amount of cholesterol your LDL particles are carrying, not how many particles there are. Your HbA1c and glucose tell you about blood sugar, but only after it has already started to rise. In other words, the standard panel is good at telling you when a problem has arrived. It is not designed to tell you it is coming.[1][4]

That is the gap a longevity panel is built to close. It keeps everything the standard physical does and adds the markers that show risk earlier and more precisely. The rest of this guide is what those additions actually are.

A longevity panel adds

ApoB (your particle number), Lp(a) (an inherited risk), hs-CRP (silent inflammation), and fasting insulin (early resistance): the markers that catch cardiovascular and metabolic risk years earlier.

A standard physical has

A blood count, a metabolic panel, a standard lipid panel, and often HbA1c and thyroid. A solid baseline that tells you a problem has arrived, but is not built to show it coming.

Section 02 / ApoB and Lp(a)

ApoB and Lp(a): the cholesterol story your lipid panel misses

Here is the single most useful upgrade to a standard lipid panel: ApoB. Every artery-clogging particle in your blood, every LDL and a few others, carries exactly one ApoB protein, so measuring ApoB counts the actual number of particles driving atherosclerosis rather than the cholesterol riding inside them. This matters because two people can have the same LDL cholesterol while one has far more, smaller particles doing the damage. That mismatch is common in people with diabetes, high triglycerides, or metabolic syndrome, and it is exactly the person whose standard panel can read reassuringly while risk is higher than it looks. Major cardiovascular guidelines now list a high ApoB as a risk-enhancing factor for this reason.[1][7]

Then there is Lp(a), pronounced LP-little-a, which almost no standard physical measures and most people have never heard of. Lp(a) is a cholesterol particle you inherit; your level is roughly 80 to 90 percent genetic, stays fairly stable your whole life, and is an independent, causal risk factor for cardiovascular disease and aortic valve problems. Roughly 1 in 5 people have an elevated level, and because diet and statins barely move it, knowing your number changes how aggressively you and your clinician manage everything else. The best part is that because it is stable, you generally only need to measure it once in your life.[2] If you have a family history of early heart disease and have never had your Lp(a) checked, that is a real gap.

Neither of these is exotic or experimental. They are standard-of-care tools that a standard physical simply does not order by default.

Curious what your last panel missed in Charleston? A longevity panel adds the markers a standard physical skips, read with you by a clinician. See what we run on the advanced testing page, or call 843-981-0870 to talk through which markers matter for you.
Section 03 / Inflammation and insulin

Inflammation and insulin: trouble that shows up early

Two more markers catch problems while they are still quiet. The first is high-sensitivity CRP, or hs-CRP, a sensitive measure of low-grade inflammation in the body. Inflammation is part of how arteries become diseased, and hs-CRP predicts cardiovascular events independent of your cholesterol. In the JUPITER trial, people with normal LDL cholesterol but an elevated hs-CRP who were given a statin had a 44 percent lower relative risk of major cardiovascular events than those on placebo, which is why the marker earned its place.[3] One honest caveat: hs-CRP rises with any infection or injury, so a single high value should be rechecked when you are well before anyone reads too much into it.

The second is fasting insulin, often paired with a calculation called HOMA-IR, and it may be the most underused test in a standard physical. Insulin resistance, the root of most metabolic disease, can be present for years before your blood sugar ever looks abnormal, because your pancreas quietly pumps out more and more insulin to keep glucose normal, until one day it can no longer keep up.[4] A standard physical checks glucose and HbA1c, which both rise late in that process, so they tend to catch the problem after the compensation has failed. By the time an HbA1c reaches the prediabetes range of 5.7 percent, that strain has usually been building for years.[6] Measuring fasting insulin lets you see the strain earlier, while it is still very reversible with diet, movement, and sleep.

That early-warning quality is the whole theme here. The standard markers are not wrong. They just ring the alarm later than you would want.

Section 04 / The panel

The longevity panel at a glance

So what actually goes on a longevity panel, and what does each piece add? The table below lines up the core markers, what each one measures, and whether a standard physical already covers it, so you can see the additions at a glance. Treat it as a map, not a shopping list; which markers make sense depends on you.

A risk a standard panel never looks for. Lp(a) is an inherited cardiovascular risk factor. A standard lipid panel does not measure it. People with elevated Lp(a)~1 in 5 (20%) Standard panels that check itEssentially none Elevated Lp(a) affects roughly 1 in 5 people and is measured once in a lifetime, yet it is not on a standard panel. Source: National Lipid Association.
A genetic risk that affects one in five people, and that a standard physical does not even check.
MarkerWhat it measuresOn a standard physical?
ApoBThe number of artery-clogging particlesUsually not
Lp(a)An inherited, lifelong cardiovascular risk factorNo
hs-CRPLow-grade inflammation linked to heart riskNo
Fasting insulin / HOMA-IRInsulin resistance, often years earlyUsually not
Standard lipid panelTotal, LDL, HDL cholesterol and triglyceridesYes
HbA1c / fasting glucoseBlood sugar, average and fastingOften
Which location fits you?

Six things to weigh

Tick the ones your last panel actually measured. The ones you cannot tick are the gaps worth closing.

Two honest notes on that table. First, more markers is not automatically better; an unfocused panel produces numbers no one acts on, which is just anxiety with a lab bill. The value is in measuring the right things for your history and then doing something with the results. Second, cost varies by how comprehensive the panel is, which is why we keep a plain breakdown on our guide to advanced lab testing cost in Charleston so you can see what a fuller panel runs before you commit.

Section 05 / The extras

The extras, and what they can and cannot tell you

Beyond the core markers, a longevity panel often adds context tests, and here honesty matters, because some are more useful than the marketing suggests. A few are genuinely informative. GGT, a liver enzyme, independently tracks with cardiovascular and overall mortality and flags metabolic strain and fatty liver.[5] Thyroid testing catches dysfunction that quietly alters your metabolism, energy, and lipids. Vitamin D identifies a deficiency worth correcting for bone and muscle health, though it is worth knowing that correcting it has not been shown to lower cardiovascular events in trials.

Others are best read with caution, and a good clinic will tell you so. Homocysteine is associated with cardiovascular risk, but lowering it with B vitamins did not reduce events in trials, so it is a marker to interpret, not a number to chase. Hormone levels like testosterone and estradiol are useful for evaluating symptoms and hormonal status, but they are not validated longevity predictors, and reading them as a longevity score overstates what they can do. The skill is not in ordering the longest list. It is in knowing which numbers should change what you do, and which are just interesting.

That is really the difference between a longevity panel done well and a panel dumped on you as a PDF. The tests are the easy part. Interpreting them in the context of your history, and acting only where acting helps, is the part that makes them worth it.

Section 06 / Getting it done

Getting a longevity panel in Charleston

If you want more than the standard physical gives you, a longevity panel in Charleston is straightforward to get, and the thing that makes it valuable is not the length of the list but who reads it. The right panel starts from your history and goals, measures the markers that matter for you, and comes with a clinician who explains what each result means and what, if anything, to do about it.

At Solcara, advanced testing is built that way: the core cardiovascular and metabolic markers a standard physical misses, the context tests that are actually informative, and a real conversation about the results rather than a portal full of numbers. If you would rather start with a thorough baseline, our annual full panel labs are a good first step, and if you are exploring longevity care more broadly, our honest look at NAD and other longevity therapies is written in the same evidence-first spirit. Call 843-981-0870 and we will help you figure out which markers are worth measuring for you.

Advanced Testing at Solcara

The longevity panel and how we actually read it. Read Advanced Testing at Solcara.

Annual Full Panel Labs

A thorough baseline to build from. Read Annual Full Panel Labs.

Advanced Lab Testing Cost in Charleston

What a fuller panel runs, in plain numbers. Read Advanced Lab Testing Cost in Charleston.

Ask Ashley
Ashley Harwyn, PA-C Ashley Harwyn, PA-C PA-C, ABAAHP · Founder, Solcara Health Online

Tap a question to ask

Measure what actually matters

A longevity blood panel at The Longevity Club, 163 Rutledge Avenue downtown, or our Mount Pleasant office: the markers a standard physical misses, read with you by a clinician.

BOOK A CONSULTATION →

Or call 843-981-0870

About the author
Ashley Harwyn, PA-C, founder of Solcara Health in Charleston, South Carolina.

Ashley Harwyn, PA-C, ABAAHP

Founder, Solcara Health · Diplomate, American Board of Anti-Aging Health Practitioners (ABAAHP)

Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.

Full bio →

References

The AHA/ACC cholesterol guideline, National Lipid Association statements on apoB and Lp(a), the JUPITER trial, ADA Standards of Care, and peer-reviewed work on insulin resistance and GGT, each accessed October 1, 2026.

  1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019. ahajournals.org
  2. Wilson DP, Jacobson TA, Jones PH, et al. Use of Lipoprotein(a) in Clinical Practice: A Biomarker Whose Time Has Come (National Lipid Association Scientific Statement). Journal of Clinical Lipidology. 2019. lipidjournal.com
  3. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (JUPITER). New England Journal of Medicine. 2008. nejm.org
  4. Early Insulin Resistance in Normoglycemic Low-Risk Individuals (review of insulin resistance preceding dysglycemia). 2023. pmc.ncbi.nlm.nih.gov
  5. Ruttmann E, Brant LJ, Concin H, et al. Gamma-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality. Circulation. 2005. ahajournals.org
  6. American Diabetes Association. Standards of Care in Diabetes: Diagnosis and Classification. 2026. diabetesjournals.org
  7. Behbodikhah J, Ahmed S, Elyasi A, et al. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target (National Lipid Association apoB consensus context). 2024. ncbi.nlm.nih.gov

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. It describes a regulatory labeling change and general treatment categories; it is not a recommendation that any individual start, stop, or change a medication. Hormone therapy of any kind, including local vaginal estrogen, requires evaluation by a qualified, licensed clinician who knows your personal and family history. Consult a qualified healthcare provider before making medical decisions. Information reflects sources available as of October 1, 2026.

Ashley Harwyn, PA-C, ABAAHP, is a Diplomate of the American Board of Anti-Aging Health Practitioners (ABAAHP) through A4M and the founder of Solcara Health. Solcara serves South Carolina from Downtown Charleston (163 Rutledge Ave, Ste 202, The Longevity Club) and Mt. Pleasant (496 Bramson Ct, Ste 120).

Return to blog